# 1. Financial Performance ## A. Key Figures * **Revenue (Q4 FY26):** **₹2,580 Cr** ($283M) (+19.5% YoY / +11.6% CC) * **Revenue (FY26):** **₹9,560 Cr** ($1,082M) (+19.7% YoY / +13.6% CC) * **EBIT Margin:** 12.2% Q4 (+100 bps YoY) · 11.7% FY26 (+74 bps YoY) * **PAT:** **₹210 Cr** Q4 (+27.7% YoY) · **₹670 Cr** FY26 (+13.5% YoY) * **Cash & Debt:** **₹3.1 Bn** Cash · **₹16.3 Bn** Net Debt * **Efficiency Metrics:** 66 days DSO · 17.7% ROCE · 160% FCF/PAT ## B. Revenue Growth * **Billion-Dollar Milestone:** Achieved the $1 billion annual revenue mark a full year ahead of schedule, underpinned by eight consecutive quarters of double-digit growth. * **Organic vs. Inorganic Mix:** Robust organic growth of approximately **9.8% to 9.9%** was supplemented by strategic acquisitions (TeleMedik, Ascensos, PDC), with TeleMedik contributing **130 bps** to Q4 sequential growth. * **Revenue Resilience:** High visibility maintained through a business model focused on annuity and recurring revenue, which remains less sensitive to discretionary spending volatility than traditional IT services. ## C. Profitability & Margins * **Consistent Margin Expansion:** Delivered the sixth consecutive quarter of operating margin improvement, exceeding the annual expansion target of **50-75 bps**. * **Operational Drivers:** Profitability gains supported by a technology-first approach in the healthcare segment and disciplined financial execution. * **Tax Outlook:** Effective tax rate remains stable, with FY27 guidance projected between **20% and 22%**. ## D. Cash Flow & Capital Allocation * **Strong Cash Conversion:** Exceptional liquidity profile evidenced by high cash conversion rates and an improved return on capital employed. * **Deleveraging Trend:** While net debt increased YoY to fund acquisitions, the pace of debt accumulation slowed significantly to **INR 200 Cr** this year compared to **INR 700 Cr** previously. * **Balanced Allocation:** Strategy remains committed to returning **40% to 50%** of cash flow to shareholders while reserving the balance for opportunistic tuck-in acquisitions to bridge capability gaps. --- # 2. Client & Deal Momentum ## A. Key Figures * **Large Deal Wins (>$5M ACV):** **4** in Q4 · **17** in FY26 (vs. 14 in FY25) * **New Client Additions:** **11** in Q4 · **47** in FY26 * **Strategic Logos (>$5M Potential):** **6** in Q4 · **24** in FY26 (2x YoY) * **Deal Pipeline:** **>$1B** (Record High) ## B. Large Deal & Pipeline Momentum * **Consistent Execution:** Achieved a fifth consecutive quarter with at least four large deal signings, underpinned by a dedicated pursuit team and a record-high pipeline. * **Market Share Capture:** Growth is fueled by a "challenger brand" strategy, leveraging macro shifts and a trend of clients moving away from **insourced operations** toward creative commercial constructs. * **Integrated Service Demand:** Clients are increasingly pivoting toward a "design, build, and run" model, seeking single-partner accountability for end-to-end operational transformation. * **Sector-Specific Strength:** Financial services momentum is particularly high among **midsized banks and fintechs** focusing on AI integration across the customer lifecycle. ## C. Strategic Logo & Account Scaling * **Accelerated Acquisition:** Strategic client additions doubled year-over-year, with nearly half of all new FY26 clients categorized as having high revenue potential. * **Proven Mining Capabilities:** Demonstrated strong account farming by converting **50%** of strategic logos added in the last 24 months into active accounts exceeding the $5 million threshold. * **Global Footprint Expansion:** Recent wins span diverse geographies and sectors, including a **US fintech leader**, an **Australian water utility**, and a **UK-based MVNO**. ## D. Client Concentration & Visibility * **De-risking the Portfolio:** Revenue concentration has significantly diversified over the last eight quarters, with the top 10 clients' share decreasing by **12%** even as they continue to grow at industry rates. * **Long-term Revenue Predictability:** New contracts are increasingly transformative and phased, providing enhanced long-term visibility as revenue converts upon reaching specific milestones. * **Delivery Shift:** Top-tier clients are successfully transitioning from onshore to **nearshore delivery** models without compromising growth trajectories. --- # 3. Vertical & Geography Performance ## A. Key Figures * **BFS Growth (CC):** **9%** YoY · **5%** Sequential * **Healthcare Growth (CC):** **16%** YoY · **10%** Sequential * **CMT Growth (CC):** **3%** YoY · **-4%** Sequential * **Diverse Portfolio Growth (CC):** **23%** YoY · **-8%** Sequential * **North America Growth (CC):** **14%** YoY · **4%** Sequential * **Europe Growth (CC):** **4%** YoY · **0%** Sequential ## B. Healthcare & BFS * **Vertical Momentum:** Robust double-digit growth in Healthcare driven by broad-based demand and **one new logo** addition across payer and provider segments. * **BFS Drivers:** Steady expansion fueled by regulatory compliance, financial crime prevention, and AI-led transformation initiatives. * **AI Implementation:** Successfully deployed governed AI agents for a leading US financial institution to manage end-to-end collections operations. ## C. CMT & Diverse * **CMT Volatility:** Modest annual growth offset by a sequential dip due to program transitions and timing of work packets in consumer tech. * **Diverse Portfolio Dynamics:** Significant annual surge tempered by seasonal retail dips; portfolio strengthened by **four new logos**, including two major retail clients. * **Future CMT Pipeline:** Growth expected to normalize as transitions conclude, supported by client demand for AI training data and tech-led solutions. ## D. North America Momentum * **Regional Expansion:** Broad-based momentum across core verticals with new sales operations established in **Canada** to sustain growth. * **Capability Replication:** Strategically exporting UK-based utilities and retail expertise to the US market, supported by the appointment of a **new utility business head**. ## E. Europe & UK * **UK Strategic Wins:** Secured regulatory approval for collections and won **two large deals** in the banking sector despite a soft macroeconomic environment. * **Operational Shift:** European performance increasingly driven by a transition toward offshore and nearshore delivery models. * **Pipeline Strength:** Regional sales pipeline has expanded by **60%** over the last four quarters, bolstered by the **Pastdue Credit** acquisition. --- # 4. Operational & Talent Strategy ## A. Key Figures * **Total Headcount:** **36,205** employees · **+1,554** net YoY increase * **Hiring Mix:** **~80%** gross additions from offshore/nearshore locations * **Attrition:** **29.7%** LTM (-600 bps over eight quarters) ## B. Talent Strategy & Utilization * **Strategic Workforce Pivot:** Global headcount expansion supports a transition toward becoming an AI-enabled "global intelligence partner" rather than a traditional service provider. * **Specialized Talent Acquisition:** Shifting recruitment focus toward **forward-deployed engineers** and AI-domain experts to solve "last-mile" client integration challenges. * **Margin Balancing:** Management is actively weighing the higher cost of specialized talent against long-term margin aspirations and investment requirements. ## C. Delivery Center Mix & Stability * **Enhanced Workforce Stability:** Significant multi-quarter improvement in attrition rates suggests better employee retention and operational continuity. * **Nearshore Expansion:** The TeleMedik acquisition adds a strategic delivery hub in **Puerto Rico**, providing a US-compliant, cost-efficient alternative for healthcare and diversified sectors. --- # 5. Technology & Strategic Initiatives ## A. Key Figures * **Revenue per Employee:** **12% increase** over the last two years * **M&A Growth Contribution:** **1.3%** from TeleMedik (Q4 YoY CC) · **1.5%** from Pastdue & TeleMedik (FY26) * **M&A Outlook:** **2% to 2.5%** projected contribution in FY27 ## B. Agentic Operating Model * **Structural Pivot:** Shifting from traditional labor-based "UnBPO" to "Intelligence that Operates," prioritizing AI agents with domain judgment over headcount growth. * **Commercial Model Evolution:** Transitioning from per-seat pricing to outcome-linked delivery and platform fees, where the firm underwrites specific results for regulated industries. * **Strategic Partnership:** Modernizing collections for a leading US payments institution via a digital platform featuring a governed autonomous collector. * **Operational Safeguards:** Implementing "human-in-the-loop" overrides and process harnesses to ensure governance in high-stakes, regulated workflows. ## C. Kairos Platform & AI-First Transition * **Proprietary Tech Stack:** Leveraging the Kairos platform to encode 25 years of domain expertise into portable, composable learning loops that run within client environments. * **TAM Expansion:** Rapid AI advancement has structurally widened the addressable market, allowing the firm to capture demand for full-scale operating model redesigns. * **Investment Funding:** AI-native capabilities and GTM strategies are being financed through internal automation, increased offshoring, and nearshoring efficiencies. * **Market Positioning:** Differentiating from tool-only tech firms and labor-heavy service providers by acting as a single-motion partner for advisory and operational management. ## D. M&A Integration * **Inorganic Momentum:** Recent acquisitions of Pastdue Credit and TeleMedik are successfully integrated, with their growth contribution expected to accelerate in the coming fiscal year. --- # 6. Risks & Service Volatility ## A. Key Figures * Hedge Book (GBP): GBP54.5 million 12-month forward (Avg. Rate: 117) * **Hedge Book (USD):** **$107.8 Mn** 12-month forward (Avg. Rate: **91.5**) ## B. Regulatory & Operational Timing * **UK Collections Recovery:** Operations are now active following the resolution of regulatory delays that previously hindered Q4 performance; the deal is expected to provide a tailwind in Q1 FY27. * **Healthcare Payer Headwinds:** Q4 results were pressured by a temporary suspension of Medicare Advantage ramp-ups following tighter January 2026 regulations and flat rates. * **Demand Resilience:** Despite regulatory timing shifts, demand for outcome-led efficiency programs remains intact as payers navigate a more restrictive environment. ## C. GenAI Strategy & Market Positioning * **Counter-Cannibalization Narrative:** Management asserts that robust growth and FY27 guidance refute GenAI cannibalization fears, supported by early commercial traction of the "Intelligence that operates" initiative. * **Implementation Barriers:** Significant "scaffolding work" regarding data quality and security guardrails is required before GenAI can automate complex operations for large-scale enterprise clients. --- # 7. Guidance & Outlook ## A. Key Figures * **FY27 Revenue Growth (CC):** **10% to 13%** Total Guidance · **~9%** Organic Midpoint · **~2%** Inorganic Contribution * **FY27 EBIT Margin:** **12.25% to 12.75%** Guidance Range * **Long-term Targets:** **14% to 15%** EBIT Margin Band · **50 to 75 bps** Annual Margin Improvement ## B. Revenue Growth Targets * **Industry Benchmarking:** FY27 guidance positions the firm in the top decile of global IT and BPO sector growth. * **Growth Distribution:** Revenue is expected to be evenly spread across all four quarters rather than back-ended, supported by a robust **₹100 crore plus** pipeline. * **Visibility & Strategy:** Management maintains high visibility for the lower end of guidance based on current project ramps, leveraging macroeconomic shifts to establish new growth engines over a **3-5 year** horizon. ## C. Margin Expansion Goals * **Profitability Trajectory:** The FY27 margin floor is set higher than the previous year's exit rate, marking the first step toward the long-term profitability goal. * **Operational Efficiency:** Management remains committed to reaching a mid-teen EBIT band within the next couple of years through consistent annual basis point improvements.